AR and prostate carcinoma: In LNCaP95 prostate cancer cells, the Hsp70 inhibitor 1 induced apoptosis and suppressed the expression of the full-length androgen receptor (AR-FL) and of the androgen receptor splice variant 7 (AR-V7), which are associated with castration-resistant prostate cancer (CRPC) [23].